Indeed, studies have demonstrated that exogenous administration of BDNF may be considered a promising tool for diverse types of neurodegenerative disorders including brain disease, olfactory impairment, and sensorineural hearing loss. The gene discussed is BDNF; the disease is sensorineural hearing loss disorder.